Discover the complete record of transactions filed by 박한수, Directeur Exécutif. Director active across 2 companies, notably 비보존 제약. In total, 18 disclosures have been published. The latest transaction was filed on 30 April 2026 — Purchase. Regulator: DART (FSS). The full history is free.
Park Han-soo is an Executive Director at Bivision Pharmaceuticals. In this role, he oversees operations and participates in implementing the company’s strategy. His experience in the pharmaceutical sector enables him to guide the company towards sustainable growth and enhance the services offered to clients.